When it comes to weight loss, finding the right solution can feel like searching for a needle in a haystack. For many, Ozempic has emerged as a standout ...

Recent clinical studies have revealed groundbreaking developments in treating knee osteoarthritis through metabolic ...

Novo Nordisk, the maker of Ozempic, Rybelsus and Wegovy ... of Boards of Pharmacy has sent up a Safe Site Search Tool which allows users to verify if a website selling medications has been vetted. You ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October ...

Wednesday’s update to the regulator’s drug shortage database is good news for Novo Nordisk, which has struggled to keep up ...

Last month, Novo Nordisk asked the U.S. FDA to ban compounding pharmacies from making copycat versions of Wegovy and Ozempic, which it said were too complex for those manufacturers to produce safely.

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

It means that while Ozempic or many other top-selling versions are not in India and even if they were, they could have been ...